The co‐occurrence of BRAF mutation and MSI was mainly due to an elevated level of CpG island methylator phenotype (CIMP) and MLH1 promoter methylation in BRAF mutant CRC.15 The gene discussed is BRAF; the disease is colorectal carcinoma.